159 related articles for article (PubMed ID: 7149168)
1. Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function.
Ammann AJ
Am J Pediatr Hematol Oncol; 1982; 4(3):301-6. PubMed ID: 7149168
[TBL] [Abstract][Full Text] [Related]
2. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
[TBL] [Abstract][Full Text] [Related]
3. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
Kaplan J; Sarnaik S; Schiffman G
Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
5. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
[TBL] [Abstract][Full Text] [Related]
7. [Pneumococcal vaccination--yes or no?].
Hess T
Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1096-103. PubMed ID: 9691344
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
[TBL] [Abstract][Full Text] [Related]
9. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
[TBL] [Abstract][Full Text] [Related]
10. Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine.
Ammann AJ; Schiffman G; Addiego JE; Wara WM; Wara DW
Rev Infect Dis; 1981; 3 Suppl():S160-7. PubMed ID: 7280446
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia.
Chintu C; Gupta K; Osborne C; Masona JM
Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155
[No Abstract] [Full Text] [Related]
12. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Antin JH; Guinan EC; Avigan D; Soiffer RJ; Joyce RM; Martin VJ; Molrine DC
Biol Blood Marrow Transplant; 2005 Mar; 11(3):213-22. PubMed ID: 15744240
[TBL] [Abstract][Full Text] [Related]
13. Indications for pneumococcal vaccine in patients with impaired splenic function.
Ammann AJ; Diamond LK
N Engl J Med; 1978 Oct; 299(14):778. PubMed ID: 29221
[No Abstract] [Full Text] [Related]
14. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
Landesman SH; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency.
de Montalembert M; Lenoir G
Ann Hematol; 2004 Jan; 83(1):18-21. PubMed ID: 14534810
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to invasive bacterial infections in children with sickle cell disease.
Battersby AJ; Knox-Macaulay HH; Carrol ED
Pediatr Blood Cancer; 2010 Sep; 55(3):401-6. PubMed ID: 20232448
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal vaccines: World Health Organization position paper.
Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
[TBL] [Abstract][Full Text] [Related]
19. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
Siber GR; Weitzman SA; Aisenberg AC
Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
[TBL] [Abstract][Full Text] [Related]
20. Polyvalent pneumococcal vaccines: a review.
Hales K; Barriere SL
Am J Hosp Pharm; 1979 Jun; 36(6):773-7. PubMed ID: 380332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
